Oral anticoagulation on patients with atrial fibrillation: are we doing a good job?

Atrial fibrillation (AF) is one of the major causes of stroke and cardiovascular morbidity in the world [ 1 ]. Oral anticoagulation (OAC) with vitamin K antagonists (VKAs) or non-VKA oral anticoagulants (NOACs) reduces the risk of such events in AF patients [ 1-3 ]. Our aim was to evaluate if AF pat...

Full description

Saved in:
Bibliographic Details
Published in:Annals of medicine (Helsinki) 2021-04, Vol.53 (S1), p.S206-S206
Main Authors: Lima, Joana C. F., Aguiar, João, Ferreira, Margarida Paixão, Calixto, Rita, Cesário, Vera, Vaz, José
Format: Article
Language:English
Subjects:
Abstract
Abstract 86
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Atrial fibrillation (AF) is one of the major causes of stroke and cardiovascular morbidity in the world [ 1 ]. Oral anticoagulation (OAC) with vitamin K antagonists (VKAs) or non-VKA oral anticoagulants (NOACs) reduces the risk of such events in AF patients [ 1-3 ]. Our aim was to evaluate if AF patients were correctly hypocoagulated and the prevalence of acute ischaemic stroke (IS) and acute transient ischaemic attack (TIA) among these patients. A cross-sectional study was undertaken in a Portuguese hospital in Beja in the last three months. Patients (aged 18 years or older) with previous history of AF admitted to internal medicine ward were included. Data was extracted from medical charts, which included sociodemographic and clinical variables. To assess if patients were correctly medicated or in need for OAC, we calculated CHA 2 DS 2 -VASc (if
ISSN:0785-3890
1365-2060
DOI:10.1080/07853890.2021.1896844